Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice

Pharmacology Biochemistry and Behavior - Tập 209 - Trang 173257 - 2021
Nobue Kitanaka1, F. Scott Hall2, Shotaro Kobori1, Sota Kushihara1, Hiroyuki Oyama1, Yasuki Sasaoka1, Megumi Takechi1, Koh-ichi Tanaka3, Kazuo Tomita4, Kento Igarashi4, Nobuyoshi Nishiyama3, Tomoaki Sato4, George R. Uhl5,6, Junichi Kitanaka1
1Department of Pharmacology, Hyogo College of Medicine, Hyogo 663-8501, Japan
2Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA
3Division of Pharmacology, Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Hyogo 650-8530, Japan
4Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan
5Neurology and Research Services, New Mexico VA Healthcare System, Albuquerque, NM 87108, USA
6Departments of Neurology, Neuroscience, Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, USA

Tài liệu tham khảo

Alfaro-Rodriguez, 2013, Histamine H3 receptor activation prevents dopamine D1 receptor-mediated inhibition of dopamine release in the rat striatum: a microdialysis study, Neurosci. Lett., 552, 5, 10.1016/j.neulet.2013.07.026 Aquino-Miranda, 2016, Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens, Neuropharmacology, 106, 91, 10.1016/j.neuropharm.2015.07.006 Beaven, 1979, New inhibitors of histamine-N-methyltransferase, Biochem. Pharmacol., 28, 183, 10.1016/0006-2952(79)90500-8 Bolam, 2016, Histamine and the striatum, Neuropharmacology, 106, 74, 10.1016/j.neuropharm.2015.08.013 Brackins, 2011, Treatments for methamphetamine abuse: a literature review for the clinician, J. Pharm. Pract., 24, 541, 10.1177/0897190011426557 Cavallito, 1978, Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man, Drug Metab. Dispos., 6, 329 Cretzmeyer, 2003, Treatment of methamphetamine abuse: research findings and clinical directions, J. Subst. Abus. Treat., 24, 267, 10.1016/S0740-5472(03)00028-X Cruickshank, 2009, A review of the clinical pharmacology of methamphetamine, Addiction, 104, 1085, 10.1111/j.1360-0443.2009.02564.x Gianutsos, 1982, Dopaminergic properties of nomifensine, Pharmacol. Biochem. Behav., 17, 951, 10.1016/0091-3057(82)90478-6 Greberman, 1994, Social and legal factors related to drug abuse in the United States and Japan, Public Health Rep., 109, 731 Hamel, 2020, Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature, Syst. Rev., 9, 245, 10.1186/s13643-020-01499-z Ito, 1996, Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine, J. Pharmacol. Exp. Ther., 279, 271 Ito, 1997, The effect of methamphetamine on histamine release in the rat hypothalamus, Psychiatry Clin. Neurosci., 51, 79, 10.1111/j.1440-1819.1997.tb02911.x Itoh, 1984, Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice, Neurosci. Lett., 48, 305, 10.1016/0304-3940(84)90055-7 Iwabuchi, 2004, Methamphetamine and brain histamine: a study using histamine-related gene knockout mice, Ann. N. Y. Acad. Sci., 1025, 129, 10.1196/annals.1316.016 Kalivas, 1982, Histamine-induced arousal in the conscious and pentobarbital-pretreated rat, J. Pharmacol. Exp. Ther., 222, 37 Karila, 2010, Pharmacological approaches to methamphetamine dependence: a focused review, Br. J. Clin. Pharmacol., 69, 578, 10.1111/j.1365-2125.2010.03639.x Kitanaka, 2003, Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration, Eur. J. Pharmacol., 474, 63, 10.1016/S0014-2999(03)02015-6 Kitanaka, 2006, Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-a inhibitor, Neurochem. Res., 31, 829, 10.1007/s11064-006-9087-x Kitanaka, 2006, Methamphetamine reward in mice as assessed by conditioned place preference test with supermex sensors: effect of subchronic clorgyline pretreatment, Neurochem. Res., 31, 805, 10.1007/s11064-006-9081-3 Kitanaka, 2007, Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors, Neuroscience, 147, 765, 10.1016/j.neuroscience.2007.05.006 Kitanaka, 2010, Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice, Pharmacol. Biochem. Behav., 94, 464, 10.1016/j.pbb.2009.10.009 Kitanaka, 2010, Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice, Neurochem. Res., 35, 749, 10.1007/s11064-010-0132-4 Kitanaka, 2011, Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine, Neurochem. Res., 36, 1824, 10.1007/s11064-011-0500-8 Kitanaka, 2012, Attenuation of methamphetamine-induced conditioned place preference in mice after a drug-free period and facilitation of this effect by exposure to a running wheel, J. Exp. Neurosci., 6, 11, 10.4137/JEN.S10046 Kitanaka, 2012, A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period, Brain Res., 1429, 155, 10.1016/j.brainres.2011.10.037 Kitanaka, 2016, Brain histamine N-methyltransferase as a possible target of treatment for methamphetamine overdose, Drug Target Insights, 10, 1, 10.4137/DTI.S38342 Kitanaka, 2017, How the histamine N-methyltransferase inhibitor metoprine alleviates methamphetamine reward, J .Addict. Med. Ther. Sci., 3, 16, 10.17352/2455-3484.000021 Kitanaka, 2020, In vivo evaluation of effects of histamine H3 receptor antagonists on methamphetamine-induced hyperlocomotion in mice, Brain Res., 1740, 10.1016/j.brainres.2020.146873 Knigge, 1988, Histaminergic regulation of prolactin secretion: involvement of tuberoinfundibular dopaminergic neurons, Neuroendocrinology, 48, 167, 10.1159/000125005 Kubota, 2002, Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice, J. Neurochem., 83, 837, 10.1046/j.1471-4159.2002.01189.x Lamberti, 1998, Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test, Br. J. Pharmacol., 123, 1331, 10.1038/sj.bjp.0701740 Muley, 1979, Effect of L-histidine pretreatment on methamphetamine induced sterotyped behaviour in rats, Indian J. Physiol. Pharmacol., 23, 291 Muroi, 1991, Effect of reserpine on histamine metabolism in the mouse brain, J. Pharmacol. Exp. Ther., 256, 967 Murray, 1998, Psychophysiological aspects of amphetamine-methamphetamine abuse, J. Psychol., 132, 227, 10.1080/00223989809599162 2014 Nichol, 1977, Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase, Cancer Treat. Rep., 61, 559 Okuda, 2009, Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice, J. Pharmacol. Sci., 111, 167, 10.1254/jphs.09024FP Philippu, 1984, In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus, Naunyn Schmiedeberg's Arch. Pharmacol., 326, 116, 10.1007/BF00517307 Prast, 1993, Modulation by dopamine receptors of the histamine release in the rat hypothalamus, Naunyn Schmiedeberg's Arch. Pharmacol., 347, 301, 10.1007/BF00167449 Sakai, 1992, Effects of (S)-alpha -fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice, Life Sci., 51, 397, 10.1016/0024-3205(92)90406-F Samotaeva, 2012, Metoprine induced behavioral modifications and brain regional histamine increase in WAG/Rij and wistar rats, Epilepsy Res., 101, 148, 10.1016/j.eplepsyres.2012.03.016 Sanchez-Ramos, 2015, Neurologic complications of psychomotor stimulant abuse, Int. Rev. Neurobiol., 120, 131, 10.1016/bs.irn.2015.02.003 Sato, 1992, A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis, Ann. N. Y. Acad. Sci., 654, 160, 10.1111/j.1749-6632.1992.tb25965.x Schlicker, 1993, Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors, J. Neural Transm. Gen. Sect., 93, 1, 10.1007/BF01244933 Takino, 2009, Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice, Int. Rev. Neurobiol., 85, 109, 10.1016/S0074-7742(09)85008-3 Tatsuta, 2006, Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice, Neurochem. Res., 31, 1359, 10.1007/s11064-006-9180-1 Ujike, 2004, Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis, Ann. N. Y. Acad. Sci., 1025, 279, 10.1196/annals.1316.035 Zawilska, 1985, Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors, Pol. J. Pharmacol. Pharm., 37, 821 Zhou, 2019, Effects of moderate- and high-intensity acute aerobic exercise on food reward and appetite in individuals with methamphetamine dependence, Physiol. Behav., 211, 10.1016/j.physbeh.2019.112649